168 related articles for article (PubMed ID: 31115494)
1. The efficacy of cisplatin on nasopharyngeal carcinoma cells may be increased via the downregulation of fibroblast growth factor receptor 2.
Pu L; Su L; Kang X
Int J Mol Med; 2019 Jul; 44(1):57-66. PubMed ID: 31115494
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated fibroblasts secrete FGF5 to inhibit ferroptosis to decrease cisplatin sensitivity in nasopharyngeal carcinoma through binding to FGFR2.
Liu F; Tang L; Liu H; Chen Y; Xiao T; Gu W; Yang H; Wang H; Chen P
Cell Death Dis; 2024 Apr; 15(4):279. PubMed ID: 38637504
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of serpin peptidase inhibitor clade C member 1 inhibits the growth of nasopharyngeal carcinoma cells.
Xu J; Ying Y; Xiong G; Lai L; Wang Q; Yang Y
Mol Med Rep; 2019 May; 19(5):3658-3666. PubMed ID: 30896875
[TBL] [Abstract][Full Text] [Related]
4. Caffeic acid phenethyl ester suppressed growth and metastasis of nasopharyngeal carcinoma cells by inactivating the NF-κB pathway.
Liang Y; Feng G; Wu L; Zhong S; Gao X; Tong Y; Cui W; Qin Y; Xu W; Xiao X; Zhang Z; Huang G; Zhou X
Drug Des Devel Ther; 2019; 13():1335-1345. PubMed ID: 31118570
[No Abstract] [Full Text] [Related]
5. TRIM24 siRNA induced cell apoptosis and reduced cell viability in human nasopharyngeal carcinoma cells.
Wang P; Shen N; Liu D; Ning X; Wu D; Huang X
Mol Med Rep; 2018 Jul; 18(1):369-376. PubMed ID: 29749443
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin suppresses proliferation, migration and invasion of nasopharyngeal carcinoma cells in vitro by repressing the Wnt/β-catenin/Endothelin-1 axis via activating B cell translocation gene 1.
Yin P; Song G; Jiang Z
Cancer Chemother Pharmacol; 2018 May; 81(5):863-872. PubMed ID: 29536130
[TBL] [Abstract][Full Text] [Related]
7. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
8. Amyloid β precursor protein silencing attenuates epithelial‑mesenchymal transition of nasopharyngeal carcinoma cells via inhibition of the MAPK pathway.
Xu J; Ying Y; Xiong G; Lai L; Wang Q; Yang Y
Mol Med Rep; 2019 Jul; 20(1):409-416. PubMed ID: 31180550
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of glucose-regulated protein 78 enhances the cytotoxic effects of curcumin on human nasopharyngeal carcinoma cells.
Yu X; Shi L; Yan L; Wang H; Wen Y; Zhang X
Int J Mol Med; 2018 Nov; 42(5):2943-2951. PubMed ID: 30226563
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma.
Wang Y; Cheng N; Luo J
J Biochem Mol Toxicol; 2017 Jul; 31(7):. PubMed ID: 28117929
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of FoxM1 sensitizes nasopharyngeal carcinoma cells to cisplatin via inhibition of MRN-ATM-mediated DNA repair.
Li D; Ye L; Lei Y; Wan J; Chen H
BMB Rep; 2019 Mar; 52(3):208-213. PubMed ID: 30638177
[TBL] [Abstract][Full Text] [Related]
12. Crucifera sulforaphane (SFN) inhibits the growth of nasopharyngeal carcinoma through DNA methyltransferase 1 (DNMT1)/Wnt inhibitory factor 1 (WIF1) axis.
Chen L; Chan LS; Lung HL; Yip TTC; Ngan RKC; Wong JWC; Lo KW; Ng WT; Lee AWM; Tsao GSW; Lung ML; Mak NK
Phytomedicine; 2019 Oct; 63():153058. PubMed ID: 31394414
[TBL] [Abstract][Full Text] [Related]
13. Keratin 6A gene silencing suppresses cell invasion and metastasis of nasopharyngeal carcinoma via the β‑catenin cascade.
Chen C; Shan H
Mol Med Rep; 2019 May; 19(5):3477-3484. PubMed ID: 30896882
[TBL] [Abstract][Full Text] [Related]
14. URG4-silencing suppresses cell proliferation in nasopharyngeal carcinoma through induction of apoptosis.
Luo XY; Yan B; Cai CF; Chen AM; Zhou M
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1717-1725. PubMed ID: 29630117
[TBL] [Abstract][Full Text] [Related]
15. Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells.
Zhou H; Liu Y; Wang C; Liu L; Wang H; Zhang Y; Long C; Sun X
J Exp Clin Cancer Res; 2018 Aug; 37(1):192. PubMed ID: 30111354
[TBL] [Abstract][Full Text] [Related]
16. ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma.
Peng H; Zhang J; Zhang PP; Chen L; Tang LL; Yang XJ; He QM; Wen X; Sun Y; Liu N; Li YQ; Ma J
J Exp Clin Cancer Res; 2019 Jan; 38(1):11. PubMed ID: 30621723
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of Sp1 suppresses cell proliferation, clonogenicity and the expressions of stem cell markers in nasopharyngeal carcinoma.
Zhang JP; Zhang H; Wang HB; Li YX; Liu GH; Xing S; Li MZ; Zeng MS
J Transl Med; 2014 Aug; 12():222. PubMed ID: 25099028
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo.
Huang Y; Tian Y; Zhao Y; Xue C; Zhan J; Liu L; He X; Zhang L
Cancer Commun (Lond); 2018 May; 38(1):15. PubMed ID: 29764490
[TBL] [Abstract][Full Text] [Related]
19. ARC is highly expressed in nasopharyngeal carcinoma and confers X-radiation and cisplatin resistance.
Wu P; Tang Y; He J; Qi L; Jiang W; Zhao S
Oncol Rep; 2013 Oct; 30(4):1807-13. PubMed ID: 23877130
[TBL] [Abstract][Full Text] [Related]
20. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
Wang Y; Wang Y; Fan X; Song J; Wu H; Han J; Lu L; Weng X; Nie G
Biochem Biophys Res Commun; 2018 Sep; 503(3):1214-1220. PubMed ID: 30017199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]